SCHEMBL7258959

SCHEMBL7258959

Cc1ccc(-c2nc3c(N)ncnc3n2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2S)cc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAPDH P04406 2/20 0.69
HSD17B10 Q99714 1/20 0.69
SLC28A2 O43868 4/20 0.59
HSPA8 P11142 3/20 0.59
EGFR P00533 1/20 0.58
ERBB2 P04626 1/20 0.58
HSPA5 P11021 2/20 0.57
NADK O95544 1/20 0.56
RXFP1 Q9HBX9 1/20 0.55
ADORA3 P0DMS8 2/20 0.52
SIRT2 Q8IXJ6 1/20 0.51
SIRT1 Q96EB6 1/20 0.51
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
HBB P68871 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13835111 0.91 GAPDH (0.83) GAPDHHSD17B10SLC28A2HSPA8EGFR
SCHEMBL7258953 0.85 GAPDH (0.70) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL15906322 0.82 GAPDH (1.00) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL1106676 0.82 GAPDH (1.00) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL1097451 0.82 GAPDH (1.00) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL1097445 0.82 GAPDH (1.00) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL1099269 0.81 GAPDH (0.83) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL1099264 0.81 GAPDH (0.83) GAPDHHSD17B10SLC28A2HSPA8HSPA5
SCHEMBL7254007 0.78 EGFR (0.60) GAPDHHSD17B10SLC28A2HSPA8EGFR
SCHEMBL30484788 0.78 SLC28A2 (0.60) GAPDHHSD17B10SLC28A2HSPA8EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003051881-A1 SUBSTITUTED PURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS BY SOLID-PHASE COMBINATORIAL STRATEGIES RIBAPHARM INC. (US) 2003-06-26 WO disclosed